While the glioma–GAM signaling axis is complex, transforming growth factor-beta 1 (TGFβ1) has been identified as a key signaling molecule mediating tumor invasion, migration, and immunosuppression in GBM [16,17]. This evidence concerns the gene TGFB1 and central nervous system cancer.